Abstract
Cap43 is a protein whose RNA is induced under conditions of severe hypoxia or prolonged elevations of intracellular calcium. Cap43 protein is expressed at low levels in normal tissues; however, in a variety of cancers, including lung, brain, melanoma, liver, prostate, breast, and renal cancers, Cap43 protein is overexpressed in cancer cells. The low level of expression of Cap43 in some normal tissues compared to their cancerous counterparts combined with the high stability of Cap43 protein and mRNA makes the Cap43 gene a new, important cancer marker. We hypothesize that the mechanism of Cap43 overexpression in cancer cells involves a state of hypoxia characteristic of cancer cells where the Cap43 protein becomes a signature for this hypoxic state.
Similar content being viewed by others
References
Blagosklonny MV.Loss of function and p53 protein stabilization.Oncogene.1997:15:1889–93.
Gardner LB, Li Q, Park MS, Flanagan WM, Semenza GL, Dang CV.Hypoxia inhibits Gi/S transition through regulation ofp27 expression.J Biol Chem. 2001:276:7919–26.
Greenblatt MS, Bennett WP, Hollstein M, Harris CC.Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.Cancer Res. 1994;54: 4855–78.
Kokame K, Kato H, Miyata T.Homocysteine-respondent genes in vascular endothelial cells identified by differential display analysis.J Biol Chem. 1996:271:295659–65.
Kurdistani SK, Arizti P, Reimer CL, Sugrue MM, Aaronson SA, Lee SW.Inhibition of tumor cell growth by RTP/rit42 and its responsiveness to p53 and DNA damage.Cancer Res. 1998:58:4439–44.
Madan A, Curtin PT.A 24-base-pair sequence 3'to the human erythropoietin gene contains a hypoxia-responsive transcriptional enhancer.Proc Nati Acad Sci USA. 1993; 90:3928–32.
Murray Gl, Taylor MC, McFadyen MC, et al.Tumor-specific expression ofcytochrome P450 CYPIBI.Cancer Res. 1997; 57:3026–31.
Muskhelishvili L, Thompson PA, Kusewitt DF, Wang C, Kadlubar FF.In situhybridization and immunohistochemical analysis of cytochrome P4501BI expression in human normal tissues.J Histochem Cytochem. 2001:49:229–36.
Salnikow K, Kluz T, Costa M.Role of Ca2+in the regulation of nickel-inducible Cap43gene expression.Toxicol Appi Pharmacol. 1999a; 160:127–32.
Salnikow K, An WG, Melillo G, Blagosklonny MV, Costa M.Nickel-induced transformation shifts the balance between HIF-I and p53 transcription factors.Carcinogenesis.1999b;20:1819–23.
Salnikow K, Blagosklonny M, Ryan H, Johnson R, Costa M.Carcinogenic nickel induces gene involved with hypoxic stress.Cancer Res. 2000a;60:38–41.
Salnikow K, Costa M, Figg WD, Blagosklonny MV.Hyper-inducibility ofhypoxia-responsive genes without p53/p21-dependent checkpoint in aggressive prostate cancer.Cancer Res. 2000b;60:5630–4.
van Belzen N, Dnjens WN, Diesveld MP, et al.A novel gene which is up-regulated during colon epithelial cell differentiation and down-regulated in colorectal neoplasms.Lab Invest. 1997;77:85-92.
Zhou D, Salnikow K, Costa M.Cap43a novel gene specifically induced by Ni2+compounds.Cancer Res. 1998:58:2182-9.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cangul, H., Salnikow, K., Yee, H. et al. Enhanced Expression of a Novel Protein in Human Cancer Cells: A Potential Aid to Cancer Diagnosis. Cell Biol Toxicol 18, 87–96 (2002). https://doi.org/10.1023/A:1015376032736
Issue Date:
DOI: https://doi.org/10.1023/A:1015376032736